Can-Fite BioPharma Ltd. Shareholders' Equity
Can-Fite BioPharma Ltd. (CANF) had Shareholders' Equity of $5.59 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-26
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.59M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $4.18M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $5.44M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $2.48M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $5.59M 20-F · filed 2026-03-26 |
| 2025-06-30 | $4.18M 6-K · filed 2025-08-28 |
| 2024-12-31 | $5.44M 20-F · filed 2026-03-26 |
| 2024-06-30 | $2.48M 6-K · filed 2025-08-28 |
| 2023-12-31 | $6.24M 20-F · filed 2026-03-26 |
| 2023-06-30 | $6.87M 6-K · filed 2024-08-29 |
| 2022-12-31 | $4.47M 20-F · filed 2026-03-26 |
| 2022-06-30 | $9.89M 6-K · filed 2023-08-31 |
| 2021-12-31 | $14.38M 20-F · filed 2025-04-14 |
| 2021-06-30 | $3.96M 6-K · filed 2022-08-25 |
| 2020-12-31 | $6.07M 20-F · filed 2024-03-28 |
| 2020-06-30 | $9.16M 6-K · filed 2020-08-27 |
| 2019-12-31 | $2.44M 20-F · filed 2023-03-30 |
| 2018-12-31 | $3.02M 20-F · filed 2022-03-24 |
| 2017-12-31 | $2.98M 20-F · filed 2021-03-25 |